aap Implantate AG (AAQ1.DE)
EUR 1.47
(19.51%)
EUR 1.47
(19.51%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -3.43 Million EUR | -113.21% |
| 2022 | -1.57 Million EUR | -163.8% |
| 2021 | -520 Thousand EUR | 88.36% |
| 2020 | -5.81 Million EUR | -184.51% |
| 2019 | -17.6 Million EUR | 202.48% |
| 2018 | -5.89 Million EUR | 21.21% |
| 2017 | -7.47 Million EUR | -5.34% |
| 2016 | -7.87 Million EUR | -26.34% |
| 2015 | -7.13 Million EUR | -520.58% |
| 2014 | -3.74 Million EUR | -88.65% |
| 2013 | 10.21 Million EUR | 128.02% |
| 2012 | 6.34 Million EUR | 23.35% |
| 2011 | 4.17 Million EUR | 20.16% |
| 2010 | 3.48 Million EUR | -47.07% |
| 2009 | 6.57 Million EUR | 76.85% |
| 2008 | 3.72 Million EUR | -20.14% |
| 2007 | 5.17 Million EUR | 601.94% |
| 2006 | 3.79 Million EUR | -135.82% |
| 2005 | 2.59 Million EUR | 109.93% |
| 2004 | -1.22 Million EUR | -84.88% |
| 2003 | 8.16 Million EUR | 2894.67% |
| 2002 | -292 Thousand EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q1 | -513.5 Thousand EUR | 59.2% |
| 2023 Q2 | -553 Thousand EUR | -7.69% |
| 2023 FY | - EUR | -113.21% |
| 2022 Q4 | -1.25 Million EUR | 0.0% |
| 2022 FY | - EUR | -163.8% |
| 2022 Q1 | -477 Thousand EUR | 53.37% |
| 2022 Q2 | -207 Thousand EUR | 56.6% |
| 2022 Q3 | -1.25 Million EUR | -507.97% |
| 2021 Q1 | -188 Thousand EUR | -325.15% |
| 2021 FY | - EUR | 88.36% |
| 2021 Q2 | 274 Thousand EUR | 245.74% |
| 2021 Q3 | -1.02 Million EUR | -473.36% |
| 2021 Q4 | -1.02 Million EUR | 0.0% |
| 2020 Q4 | 83.5 Thousand EUR | -67.25% |
| 2020 Q3 | 254.99 Thousand EUR | 111.91% |
| 2020 FY | - EUR | -184.51% |
| 2020 Q2 | -2.14 Million EUR | 1.97% |
| 2020 Q1 | -2.18 Million EUR | 4.9% |
| 2019 Q2 | -2.14 Million EUR | -115.35% |
| 2019 Q3 | -2.29 Million EUR | -6.96% |
| 2019 FY | - EUR | 202.48% |
| 2019 Q1 | -997 Thousand EUR | 23.25% |
| 2019 Q4 | -2.29 Million EUR | 0.0% |
| 2018 Q3 | -1.47 Million EUR | 3.59% |
| 2018 FY | - EUR | 21.21% |
| 2018 Q2 | -1.53 Million EUR | 3.59% |
| 2018 Q1 | -1.58 Million EUR | 38.87% |
| 2018 Q4 | -1.29 Million EUR | 11.93% |
| 2017 FY | - EUR | -5.34% |
| 2017 Q2 | -1.64 Million EUR | 1.44% |
| 2017 Q4 | -2.59 Million EUR | -65.77% |
| 2017 Q3 | -1.56 Million EUR | 4.63% |
| 2017 Q1 | -1.66 Million EUR | 23.58% |
| 2016 Q2 | -1.35 Million EUR | 37.54% |
| 2016 Q1 | -2.17 Million EUR | 62.36% |
| 2016 FY | - EUR | -26.34% |
| 2016 Q4 | -2.18 Million EUR | -23.58% |
| 2016 Q3 | -1.76 Million EUR | -30.09% |
| 2015 Q2 | -809 Thousand EUR | -523.56% |
| 2015 Q3 | 322 Thousand EUR | 139.8% |
| 2015 Q4 | -5.76 Million EUR | -1891.3% |
| 2015 FY | - EUR | -520.58% |
| 2015 Q1 | 191 Thousand EUR | 231.72% |
| 2014 Q2 | 1.51 Million EUR | 1415.0% |
| 2014 FY | - EUR | -88.65% |
| 2014 Q4 | -145 Thousand EUR | -117.92% |
| 2014 Q3 | 809 Thousand EUR | -46.6% |
| 2014 Q1 | 100 Thousand EUR | -97.97% |
| 2013 Q4 | 4.93 Million EUR | 360.26% |
| 2013 FY | - EUR | 128.02% |
| 2013 Q1 | 3.1 Million EUR | 94.85% |
| 2013 Q2 | 1.11 Million EUR | -64.13% |
| 2013 Q3 | 1.07 Million EUR | -3.6% |
| 2012 Q4 | 1.59 Million EUR | 29.45% |
| 2012 FY | - EUR | 23.35% |
| 2012 Q1 | 2.09 Million EUR | 66.77% |
| 2012 Q2 | 1.42 Million EUR | -31.82% |
| 2012 Q3 | 1.22 Million EUR | -13.88% |
| 2011 Q1 | 796 Thousand EUR | -80.01% |
| 2011 Q4 | 1.25 Million EUR | 54.75% |
| 2011 FY | - EUR | 20.16% |
| 2011 Q3 | 811 Thousand EUR | -38.65% |
| 2011 Q2 | 1.32 Million EUR | 66.08% |
| 2010 FY | - EUR | -47.07% |
| 2010 Q2 | 1.13 Million EUR | 385.9% |
| 2010 Q1 | 234 Thousand EUR | -91.02% |
| 2010 Q3 | 1.64 Million EUR | 44.24% |
| 2010 Q4 | 3.98 Million EUR | 142.74% |
| 2009 Q4 | 2.6 Million EUR | -7.52% |
| 2009 FY | - EUR | 76.85% |
| 2009 Q3 | 2.81 Million EUR | 714.45% |
| 2009 Q2 | 346 Thousand EUR | -57.23% |
| 2009 Q1 | 809 Thousand EUR | 0.0% |
| 2008 Q2 | 1.78 Million EUR | 0.0% |
| 2008 FY | - EUR | -20.14% |
| 2007 FY | - EUR | 601.94% |
| 2006 FY | - EUR | -135.82% |
| 2005 FY | - EUR | 109.93% |
| 2004 FY | - EUR | -84.88% |
| 2003 FY | - EUR | 2894.67% |
| 2002 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Drägerwerk AG & Co. KGaA | 318.33 Million EUR | 101.078% |
| Drägerwerk AG & Co. KGaA | 318.33 Million EUR | 101.078% |
| elexxion AG | -860.59 Thousand EUR | -298.792% |
| Eckert & Ziegler Strahlen- und Medizintechnik AG | 57.48 Million EUR | 105.97% |
| Geratherm Medical AG | 4.18 Million EUR | 182.019% |
| Koninklijke Philips N.V. | 1.04 Billion EUR | 100.33% |
| Stratec SE | 39.82 Million EUR | 108.619% |
| Siemens Healthineers AG | 4.22 Billion EUR | 100.081% |